139 related articles for article (PubMed ID: 6857826)
1. [Intravesical chemotherapy in superficial tumors of the bladder].
Lundbeck F
Ugeskr Laeger; 1983 Feb; 145(9):641-4. PubMed ID: 6857826
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of bladder tumors. Indications and value of loco-regional and systemic application].
Pavone-Macaluso M
Urologe A; 1983 Sep; 22 Suppl():325-31. PubMed ID: 6195795
[TBL] [Abstract][Full Text] [Related]
3. Objective response of superficial bladder tumors to intravesical treatment (including review of response of marker lesions).
Bouffioux C; van der Meijden A; Kurth KH; Jakse G; Bono A; Hall R; Oosterlinck W; Sylvester R
Prog Clin Biol Res; 1992; 378():29-42. PubMed ID: 1301584
[No Abstract] [Full Text] [Related]
4. Cytological surveillance of carcinoma in situ during and after intravesical chemotherapy.
Roth S; Rathert P
Prog Clin Biol Res; 1989; 303():523-4. PubMed ID: 2780660
[No Abstract] [Full Text] [Related]
5. Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials.
Sylvester RJ; van der Meijden AP; Witjes JA; Kurth K
J Urol; 2005 Jul; 174(1):86-91; discussion 91-2. PubMed ID: 15947584
[TBL] [Abstract][Full Text] [Related]
6. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Hofmann W; Langkopf B
Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
[No Abstract] [Full Text] [Related]
7. Intravesical therapy. A critical review.
Herr HW
Urol Clin North Am; 1987 May; 14(2):399-404. PubMed ID: 3554695
[TBL] [Abstract][Full Text] [Related]
8. [Endovesical chemotherapy for superficial bladder tumors].
Chopin D; Gattegno B
Prog Urol; 2001 Nov; 11(5):1047-64. PubMed ID: 11769074
[No Abstract] [Full Text] [Related]
9. Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
Kurth KH; Sylvester R; de Pauw M; ten Kate F
Prog Clin Biol Res; 1989; 310():125-45. PubMed ID: 2672012
[No Abstract] [Full Text] [Related]
10. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
11. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
[TBL] [Abstract][Full Text] [Related]
12. Use of clonal assay in determination of urothelial drug sensitivity in carcinoma in situ of the bladder: clinical correlations in 5 patients.
Stanisic TH; Owens R; Graham AR
J Urol; 1983 May; 129(5):949-52. PubMed ID: 6854765
[TBL] [Abstract][Full Text] [Related]
13. Intravesical instillation with adriamycin + tween 80 in patients with superficial bladder tumors: a preliminary report.
Eksborg S; Edsmyr F; Näslund I
Eur Urol; 1982; 8(4):213-5. PubMed ID: 7094962
[No Abstract] [Full Text] [Related]
14. Is intravesical chemotherapy for superficial bladder cancer still justified?
Okeke AA; Probert JL; Gillatt DA; Schwaibold H
BJU Int; 2005 Oct; 96(6):763-7. PubMed ID: 16153195
[No Abstract] [Full Text] [Related]
15. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
16. [Place of endovesical "BCG Therapy" in superficial tumors of the bladder].
Zerbib M
J Urol (Paris); 1995; 101(2):59-63. PubMed ID: 8522855
[TBL] [Abstract][Full Text] [Related]
17. [Intravesical therapy: Influence on superficial bladder cancer progression].
García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; Alvarez Múgica M; Rodríguez Robles L; Martín Benito JL; San Martín Blanco A; Regadera Sejas J
Arch Esp Urol; 2007; 60(1):31-5. PubMed ID: 17408169
[TBL] [Abstract][Full Text] [Related]
18. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder.
Lamm DL; Riggs DR; Traynelis CL; Nseyo UO
J Urol; 1995 May; 153(5):1444-50. PubMed ID: 7714962
[TBL] [Abstract][Full Text] [Related]
19. Management dilemmas in bladder cancer: radical TUR +/- systemic chemotherapy in the treatment of muscle-invasive bladder cancer.
Feneley MR; Mellon JK
Semin Urol Oncol; 2000 Nov; 18(4):300-7. PubMed ID: 11101094
[TBL] [Abstract][Full Text] [Related]
20. When should we stop intravesical treatment in patients with superficial bladder cancer?
von Heyden B; Jakse G
Recent Results Cancer Res; 1993; 126():127-33. PubMed ID: 8456183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
